Epilutein for early-stage age-related macular degeneration: A randomized and prospective study
Ophthalmic Research Oct 29, 2017
Forte R, et al. - The authors explored the proposition that oral supplementation of the epilutein/lutein combination could augment the macular pigment optical density (MPOD), in patients with age-related macular degeneration (AMD). A connection was found between the administration of lutein in combination with epilutein with an increased MPOD compared to the administration of lutein alone.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries